FRANCES HULL: Open Payments
NPI 1336531870 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,678 in 91 payments from 22 companies in 2025. Trend: 2023 $1,556 · 2024 $1,421 · 2025 $1,678
Food & beverage: $1,678
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $372 |
| PFIZER INC. | 22 | $230 |
| ABBVIE INC. | 13 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $164 |
| Novo Nordisk Inc | 9 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Corcept Therapeutics | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 2 | $35 |
Products named: NURTEC ODT, ENTYVIO, BREZTRI, LOKELMA, QULIPTA, UBRELVY, JARDIANCE, GEMTESA.
Industry payments across WA — which companies pay providers there.
